Clinical trial

Continuous Glucose Monitoring to Measure Effect of Glycemic Index

NCT01145547

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention Dexcom Seven® Plus Continuous Glucose Monitoring sensor Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Continuous Glucose Monitoring to Measure Effect of Glycemic Index

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-04-01

PhaseNA

Conditions

Type 1 Diabetes Mellitusverified · MONDO: type 1 diabetes mellitus

Interventions

Dexcom Seven® Plus Continuous Glucose Monitoring sensorDEVICE

Sponsors & collaborators

Legacy Health Systemlead sponsor

Juvenile Diabetes Research Foundationcollaborator

Mapped research locations

PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01145547 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.